CN102827054B - Hapten, artificial antigen and monoclonal antibody of L-hydroxyproline and preparation method and application thereof - Google Patents
Hapten, artificial antigen and monoclonal antibody of L-hydroxyproline and preparation method and application thereof Download PDFInfo
- Publication number
- CN102827054B CN102827054B CN201210315692.XA CN201210315692A CN102827054B CN 102827054 B CN102827054 B CN 102827054B CN 201210315692 A CN201210315692 A CN 201210315692A CN 102827054 B CN102827054 B CN 102827054B
- Authority
- CN
- China
- Prior art keywords
- oxyproline
- solution
- artificial antigen
- formula
- hydroxyproline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000427 antigen Substances 0.000 title claims abstract description 29
- 102000036639 antigens Human genes 0.000 title claims abstract description 29
- 108091007433 antigens Proteins 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 title abstract 8
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 title abstract 8
- 102000014914 Carrier Proteins Human genes 0.000 claims abstract description 13
- 108010078791 Carrier Proteins Proteins 0.000 claims abstract description 13
- 238000006243 chemical reaction Methods 0.000 claims description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 10
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 6
- 229940098773 bovine serum albumin Drugs 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 108010058846 Ovalbumin Proteins 0.000 claims description 3
- 229940092253 ovalbumin Drugs 0.000 claims description 3
- 239000008363 phosphate buffer Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 238000001514 detection method Methods 0.000 abstract description 8
- 230000002163 immunogen Effects 0.000 abstract description 5
- 238000003018 immunoassay Methods 0.000 abstract description 3
- 238000012216 screening Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 56
- 239000000047 product Substances 0.000 description 13
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 238000013019 agitation Methods 0.000 description 9
- 238000000502 dialysis Methods 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- 102000008186 Collagen Human genes 0.000 description 7
- 108010035532 Collagen Proteins 0.000 description 7
- 230000001629 suppression Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 239000008055 phosphate buffer solution Substances 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- LDJBWIOHIOWSQF-ZJUUUORDSA-N O[C@H](C[C@H]1C(O)=O)CN1C(c(cc1)ccc1O)=O Chemical compound O[C@H](C[C@H]1C(O)=O)CN1C(c(cc1)ccc1O)=O LDJBWIOHIOWSQF-ZJUUUORDSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 210000000459 calcaneus Anatomy 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 238000000207 volumetry Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
Abstract
The invention discloses a hapten, an artificial antigen and a monoclonal antibody of L-hydroxyproline, and a preparation method and application thereof. The hapten of the L-hydroxyproline contains the molecular structure of the L-hydroxyproline, and an antibody aiming at the L-hydroxyproline can be generated by taking a connector of the hapten and carrier protein as an immunogen. Therefore, the L-hydroxyproline hapten provided by the invention can be used for preparing a specific antibody of L-hydroxyproline, and is used for immunoassay and screening of L-hydroxyproline, so that the detection efficiency is improved, and the detection cost is reduced.
Description
Technical field
The present invention relates to food safety field, be specifically related to a kind of haptens, artificial antigen and monoclonal antibody and preparation method thereof and application of L-oxyproline.
Background technology
Collagen protein is present in skin, bone, heel string, cartilage, blood vessel and the tooth of animal, accounts for 1/4th of Mammals total protein, and collagen hydrolysate be can be made into animal hydrolyzed protein.Hydrolyzed animal collagen proteins not only can affect mouthfeel and local flavor after mixing milk and milk products, and makes amino acid whose ratio unreasonable, and nutritive value reduces, and nondigestible, and absorption of human body utilization ratio is reduced.Some animal hydrolyzed protein is the protein that utilizes waste material, rubbish and hair etc. to be processed into, cheap, contain carcinogens, heavy metal, a large amount of miscellaneous bacteria, especially the heavy metal chromium containing in " tanning " lower horn scraps, if be absorbed by the body, accumulate, can cause that joint is loose, arthroncus, cause body weight for humans metal poisoning, very big to harm.For this reason, ministry of Health of China is listed second batch " the non-edible material from soybeans list of the illegal interpolation of possibility in food " in by " leather skin hydrolyzate ".
L-oxyproline is peculiar amino acid in animal collagen, and in collagen protein, content approximately 10.0~13.4%, in other albumen, do not exist.Utilize this characteristic just can carry out the monitoring of collagen protolysate, by detecting L-oxyproline, identify in breast and milk-product whether added hydrolyzed animal collagen proteins.
At present, the measuring method for L-oxyproline mainly contains colorimetry, high performance liquid chromatography, tablets by HPLC-MS, automatic analyzer for amino acids assay method etc.But above method is measured the L-oxyproline in milk and milk products, respectively has deficiency.Colorimetry specificity is strong, complex operation, precision are poor, and measuring result is subject to various factors.High performance liquid chromatography needs pre-column derivatization, complicated operation.The consumptive material of tablets by HPLC-MS and automatic analyzer for amino acids assay method is expensive, cost is high makes many laboratories hope and halt.
And immune analysis method has very high tolerance range, susceptibility and specificity, and not high to technical requirements, there is detection time short, be applicable to the advantages such as mensuration in enormous quantities.Up to the present, also do not have bibliographical information to adopt immunization to detect L-oxyproline.Preparation, for the specific antibody of L-oxyproline, can, for setting up immunodetection or the research and development rapid detection product for L-oxyproline, be carried out the quick Site Detection of protolysate in milk-product and be laid the foundation with extensive generaI investigation.
Summary of the invention
One of object of the present invention is to provide a kind of haptens of L-oxyproline.
Above-mentioned purpose of the present invention reaches by the following technical programs:
A haptens for L-oxyproline, its molecular structural formula as shown in Equation 1:
Formula 1.
Two of object of the present invention is to provide the haptenic preparation method of above-mentioned L-oxyproline.
A haptenic preparation method for L-oxyproline, comprises the steps,
(a) mol ratio of L-oxyproline and p-Hydroxybenzaldehyde be set to 1: 1~2, in ethanolic soln, heating reflux reaction is 1~4 hour,
(b) after reacting completely, cooling, suction filtration, washing obtains the L-oxyproline haptens of formula 1 structure:
Formula 1.
An optimal technical scheme, is characterized in that: in described step (a), the mol ratio of L-oxyproline used and p-Hydroxybenzaldehyde is 1: 1, and in ethanol, heating reflux reaction is 2 hours.
Three of object of the present invention is to provide a kind of artificial antigen of L-oxyproline.
Above-mentioned purpose of the present invention reaches by the following technical programs:
An artificial antigen for L-oxyproline, is combined into by aforesaid L-oxyproline haptens and carrier proteins, its molecular structural formula as shown in Equation 2:
Formula 2.
An optimal technical scheme, is characterized in that: described carrier proteins is ovalbumin or bovine serum albumin.
Four of object of the present invention is to provide the preparation method of the artificial antigen of above-mentioned L-oxyproline.
The preparation method of L-oxyproline artificial antigen, comprises the steps:
(a) haptens of the L-oxyproline of formula 1 structure is dissolved in distilled water, obtain solution A, by N, N-carbonyl dimidazoles is dissolved in anhydrous propanone, obtain solution B, L-oxyproline haptens and the N of formula 1 structure used, the mol ratio of N-carbonyl dimidazoles is 1:3~8, solution A and solution B mix and blend are reacted 4~6 hours, obtain intermediate product C;
(b) described carrier proteins is dissolved in phosphate buffer soln, obtains solution D, solution C is added drop-wise in solution D, stirring reaction 11~14 hours, obtains the artificial antigen of formula 2 structures.
Five of object of the present invention is to provide a kind of monoclonal antibody of L-oxyproline.
Above-mentioned purpose of the present invention reaches by the following technical programs:
A monoclonal antibody for L-oxyproline, be can with the immunoglobulin (Ig) of the artificial antigen generation specific immune response of aforesaid L-oxyproline.
Six of object of the present invention is to provide the application of above-mentioned L-oxyproline monoclonal antibody.
Above-mentioned purpose of the present invention reaches by the following technical programs:
Described monoclonal antibody is for the immunodetection of L-oxyproline.
The molecular structure of L-oxyproline is fairly simple, is directly connected with carrier proteins as immunogen and goes immune animal can not produce specific antibody.Therefore, the structure of L-oxyproline must be carried out complicatedly, increase molecular weight, expand molecular structure.The molecular structure that the above-mentioned haptens based on L-oxyproline contains L-oxyproline, is connected preparation immunogen with carrier proteins with this haptens, can produce the antibody for L-oxyproline.Therefore, L-oxyproline compound provided by the invention can be prepared the specific antibody of L-oxyproline, for immunoassay and the screening of L-oxyproline, improves detection efficiency, reduces testing cost.
Below by specific embodiment, the present invention will be further described, but and do not mean that limiting the scope of the invention.
Embodiment
Experimental technique described in following embodiment, if no special instructions, is ordinary method; Described reagent and biomaterial, if no special instructions, all can obtain from commercial channel.
Embodiment 1
Experiment 1: the haptenic synthetic example 1 of formula 1 structure
1. in 25mL round-bottomed flask, add 131mg (0.001mol) L-oxyproline and 122mg (0.001mol) p-Hydroxybenzaldehyde;
2. add 4mL ethanol solution and several acetic acid, back flow reaction 2 hours, drains, and obtains product 175.9mg, productive rate 70%.
Formula 1.
245 ℃ of this product fusing points; Infrared spectra (IR) characterization data: (KBr) V
max3284,3300-2450,3137,2950,2732,1639,1600,1480,1400,1321,1068,962cm
-1.With the infrared data comparison of L-oxyproline, had more phenyl ring and-CO-N key.
Experiment 2: the haptenic synthetic example 2 of formula 1 structure
1. in 25mL round-bottomed flask, add 131mg (0.001mol) L-oxyproline and 244mg (0.002mol) p-Hydroxybenzaldehyde;
2. add 7mL ethanol solution and several acetic acid, back flow reaction 4 hours, drains, and obtains product 190.9mg, productive rate 76%.
Product structure and characterization data are the same.
Experiment 3: the haptenic synthetic example 3 of formula 1 structure
1. in 25mL round-bottomed flask, add 131mg (0.001mol) L-oxyproline and 183mg (0.0015mol) p-Hydroxybenzaldehyde;
2. add 5mL ethanol solution and several acetic acid, back flow reaction 1 hour, drains, and obtains product 180.9mg, productive rate 72%.
Product structure and characterization data are the same.
Experiment 4: the synthetic example 1 of the artificial antigen of formula 2 structures
1. the compound dissolution of formula 1 structure of the above-mentioned preparation of 12.6mg (0.05mmol) is in distilled water, and magnetic agitation is dissolved it completely, obtains solution A, and by 40.5mg (0.25mmol) N, N-carbonyl dimidazoles is dissolved in 3mL anhydrous propanone, obtains solution B; A solution and B solution are mixed to magnetic agitation reaction 5 hours, obtain solution C;
2. 65mg (0.001mmol) bovine serum albumin (BSA) is dissolved in the phosphate buffer solution (PBS) of the 0.01moL/L of 5mL pH7.2, obtains solution D, above-mentioned solution C is dropwise joined in solution D, magnetic agitation reaction 12 hours;
3. above-mentioned reaction solution is packed in dialysis tubing, 4 ℃ with normal saline solution dialysis 72 hours, during change dialyzate 6 times; Outwell dialyzate, the solution in dialysis tubing is carried out centrifugal, rotating speed is 4000rpm, 5 minutes time, get supernatant liquor, and be the artificial antigen of formula 2 structures, the artificial antigen of formula 2 structures is sub-packed in ampere bottle to-20 ℃ of preservations.
According to 2,4 of bibliographical information, the coupling ratio that 6-trinitro-benzene-sulfonic acid method is measured haptens and carrier proteins is 14: 1, proves the coupling of haptens and carrier proteins.2,4,6-trinitro-benzene-sulfonic acid can react with the free amine group in albumen, and the concentration of products therefrom is directly proportional to the absorbancy at ultraviolet 335nm place.Control artificial antigen and equate with the carrier proteins concentration of not coupling, with the reaction of 2,4,6-trinitro-benzene-sulfonic acid, the absorbancy of product is different, illustrates that a part of free amine group in carrier proteins has occurred to react with haptens respectively.With the difference of absorbancy, calculate the coupling ratio of haptens and carrier proteins.
Experiment 5: the synthetic example 2 of the artificial antigen of formula 2 structures
1. the compound dissolution of formula 1 structure of the above-mentioned preparation of 12.6mg (0.05mmol) is in distilled water, and magnetic agitation makes it
Dissolve completely, obtain solution A, by 24.3mg (0.15mmol) N, N-carbonyl dimidazoles is dissolved in 3mL anhydrous propanone,
Obtain solution B; A solution and B solution are mixed to magnetic agitation reaction 4 hours, obtain solution C;
2. 81mg (0.00125mmol) bovine serum albumin (BSA) is dissolved in the phosphate buffer solution (PBS solution) of the 0.01moL/L of 5mLpH7.2, obtain solution D, above-mentioned solution C is dropwise joined in solution D to magnetic agitation reaction 11 hours;
3. above-mentioned reaction solution is packed in dialysis tubing, 20 ℃ with normal saline solution dialysis 48 hours, during change dialyzate 6 times; Outwell dialyzate, the solution in dialysis tubing is carried out centrifugal, rotating speed is 4000rpm, 5 minutes time, get supernatant liquor, and be the artificial antigen of formula 2 structures, the artificial antigen of formula 2 structures is sub-packed in ampere bottle to-20 ℃ of preservations.
Experiment 6: the synthetic example 3 of the artificial antigen of formula 2 structures
1. the compound dissolution of formula 1 structure of the above-mentioned preparation of 12.6mg (0.05mmol) is in distilled water, and magnetic agitation makes it
Dissolve completely, obtain solution A, by 64.8mg (0.4mmol) N, N-carbonyl dimidazoles is dissolved in 3mL anhydrous propanone,
Obtain solution B; A solution and B solution are mixed to magnetic agitation reaction 6 hours, obtain solution C;
2. by 23mg (0.0005mmol) ovalbumin molten (OA) solution in the phosphate buffer solution (PBS solution) of the 0.01moL/L of 5mL pH7.2, obtain solution D, above-mentioned solution C is dropwise joined in solution D to magnetic agitation reaction 14 hours;
3. above-mentioned reaction solution is packed in dialysis tubing, 20 ℃ with normal saline solution dialysis 84 hours, during change dialyzate 6 times; Outwell dialyzate, the solution in dialysis tubing is carried out centrifugal, rotating speed is 4000rpm, 5 minutes time, get supernatant liquor, and be the artificial antigen of formula 2 structures, the artificial antigen of formula 2 structures is sub-packed in ampere bottle to-20 ℃ of preservations.
Embodiment 2: the preparation of antibody and evaluation
1) immune animal is prepared antiserum(antisera)
Using the artificial antigen of above-mentioned formula 2 structures as immunogen immune Balb/c mouse respectively, with the NaCl solution of 0.15mol/L, immunogen is diluted to the concentration of 1mg/mL, add equivalent Fu Shi Freund's complete adjuvant and make water in oil emulsifying agent, in the back of Babl/c mouse intracutaneous multi-point injection, carry out head and exempt from; 2 weeks, interval, gets after same amount antigen adds the emulsification of equivalent Fu Shi Freund's incomplete adjuvant and carries out the subcutaneous multi-point injection in back, is booster immunization; Booster immunization is 5 times altogether, and last booster immunization does not add adjuvant, abdominal injection.
Last immunity is extractd eyeball by mouse in latter 3 days and is got blood, and every about 2mL of the desirable blood of mouse places 5-6 hour by the blood sample of collection in 4 ℃ of refrigerators, and then 5000rpm is centrifugal 10 minutes, separation of serum.
2) purifying of antibody
Adopting sad-ammonium sulfate salting-out process to above-mentioned steps 1) antiserum(antisera) that obtains carries out purifying.Sadly under the condition of slant acidity, the protein except IgG in serum all can be precipitated, in supernatant, only have IgG.Three repetitions are established in experiment, and result shows, adopts the rate of recovery of aforesaid method IgG to reach more than 90%.
3) antiserum(antisera) lowest detectable limit (LOD value) and half amount of suppression (IC
50) detection
By square formation volumetry, determine above-mentioned steps 2) antibody of acquisition and the working concentration of artificial antigen prepared by above-described embodiment 1.
With the L-oxyproline standard solution of different concns, do experimental solutions, concentration is 0.025,0.05,0.1,0.2,0.4,0.8,1.6,3.2,6.4,12.8 (concentration unit of standard solution is μ g/mL).Adopt 8 groups of parallel tests (n=8).
Enzyme linked immuno sorbent assay (ELISA): with the artificial antigen coated elisa plate of formula 2 structures of above-mentioned working concentration, experimental solutions and antibody-solutions are added in enzyme plate aperture simultaneously, zero standard hole is set simultaneously (to be replaced the experimental solutions of interpolation with high purity water, other is consistent) and blank hole (change the antibody-solutions of interpolation into high purity water, other is consistent), 37 ℃ of incubations 0.5 hour, pour out liquid in hole, with washings (10x PBST) washing 2-5 time, enzyme plate is upside down on thieving paper and is patted; Add ELIAS secondary antibody solution in enzyme plate aperture, 37 ℃ of incubations 0.5 hour, repeat to wash 3-5 time with washings, blot; Add substrate chromophoric solution in enzyme plate aperture, under room temperature, react 10-15 minute, by microplate reader, at wavelength 450nm place, measure absorbance (OD).Take absorbancy as ordinate zou, and the logarithm (Log) of standard substance experimental solutions concentration of take is X-coordinate, draws semilog canonical plotting.
According to typical curve, draw 10% amount of suppression (LOD) and half amount of suppression (IC
50).
Inhibiting rate is calculated as follows;
In formula: the light absorption value (zero standard hole) of ODmax when not adding standard substance experimental solutions, ODx is the light absorption value of standard substance concentration while being x, ODmin is the light absorption value in blank hole.
Result shows, the half amount of suppression (IC of above-mentioned antibody to L-oxyproline
50) be 0.2 μ g/mL, lowest detectable limit (LOD) is 0.05 μ g/mL, and within the scope of 0.1-12.8 μ g/mL, the logarithmic value of inhibiting rate and L-oxyproline concentration is significant linear relationship, and relation conefficient is r=0.9984.
4) specific detection of antibody
The ability that sero-fast specificity just refers to its homospecificity antigen combination and comparison with this antigen-analogues ability.Conventional cross reacting rate is as the major criterion of evaluating.Cross reaction is less, and the specificity of antibody is better.
Several analogues of L-oxyproline (proline(Pro), D-oxyproline) being carried out to serial dilution, then with above-mentioned steps 2) antibody that obtains reacts, production standard curve.Half amount of suppression (IC while finding out respectively this several analogues generation 50% inhibition on curve
50), the cross reacting rate of calculating antibody and L-oxyproline analogue.
Cross reacting rate (%)=(the half amount of suppression of half amount of suppression/other analogue of L-oxyproline) * 100%.
Three repetitions are established in experiment, get the mean value of three repetitions as experimental result.Result shows, above-mentioned steps 2) antibody that obtains only identifies L-oxyproline, and specificity is fine, all there is no cross reactivity with proline(Pro) and D-oxyproline.Therefore, can be used as detection reagent L-oxyproline is carried out to immunoassay.
Claims (4)
1. a haptens for L-oxyproline, its molecular structural formula as shown in Equation 1:
2. an artificial antigen for L-oxyproline, its molecular structural formula as shown in Equation 2:
3. the artificial antigen of L-oxyproline as claimed in claim 2, is characterized in that, described carrier proteins is ovalbumin or bovine serum albumin.
4. the preparation method of the artificial antigen of L-oxyproline as described in claim 2 or 3, comprises the steps:
(a) haptens of the L-oxyproline of formula 1 structure is dissolved in distilled water, obtain solution A, by N, N-carbonyl dimidazoles is dissolved in anhydrous propanone, obtain solution B, haptens and the N of the L-oxyproline of formula 1 structure used, the mol ratio of N-carbonyl dimidazoles is 1: 3~8, solution A and solution B mix and blend are reacted 4~6 hours, obtain solution C;
(b) described carrier proteins is dissolved in phosphate buffer soln, obtains solution D, solution C is added drop-wise in solution D, stirring reaction 11~14 hours, obtains the artificial antigen of formula 2 structures,
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210315692.XA CN102827054B (en) | 2012-08-25 | 2012-08-25 | Hapten, artificial antigen and monoclonal antibody of L-hydroxyproline and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210315692.XA CN102827054B (en) | 2012-08-25 | 2012-08-25 | Hapten, artificial antigen and monoclonal antibody of L-hydroxyproline and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102827054A CN102827054A (en) | 2012-12-19 |
CN102827054B true CN102827054B (en) | 2014-11-12 |
Family
ID=47330397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210315692.XA Expired - Fee Related CN102827054B (en) | 2012-08-25 | 2012-08-25 | Hapten, artificial antigen and monoclonal antibody of L-hydroxyproline and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102827054B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105175531A (en) * | 2015-08-14 | 2015-12-23 | 苏州博源医疗科技有限公司 | Hydroxyproline immunogen, specific antibody and detection reagent, and preparation methods thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1271342B (en) * | 1994-12-28 | 1997-05-27 | Indena Spa | PROTEINS RICH IN HYDROXYPROLIN AND PHARMACEUTICAL AND COSMETIC FORMULATIONS CONTAINING THEM |
CN101962368A (en) * | 2010-08-17 | 2011-02-02 | 华南农业大学 | Cyanurate hapten, artificial antigen and antibody, and preparation method and applications thereof |
-
2012
- 2012-08-25 CN CN201210315692.XA patent/CN102827054B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102827054A (en) | 2012-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101271107B (en) | Fast immunology detecting method for goat milk and milk product thereof doped with cow's milk | |
CN109709338B (en) | Enzyme linked immunosorbent assay kit for detecting skeletal muscle troponin I of cattle or sheep and preparation method and application thereof | |
CHEN et al. | Monoclonal antibodies to porcine thermal‐stable muscle protein for detection of pork in raw and cooked meats | |
CN111077320B (en) | ELISA kit for detecting chicken or duck skeletal muscle troponin I and preparation method and application thereof | |
CN104119277B (en) | A kind of it is directed to the hapten of histamine, artificial antigen, antibody and preparation method and application | |
CN102279269A (en) | Preparation method of cystatin C detection kit | |
CN102827076B (en) | Universal hapten, artificial antigen and broad-spectrum monoclonal antibody for fluoroquinolone medicines as well as preparation method and application of universal hapten | |
CN101285836B (en) | Acrylic amide complete antigen preparation and its ELISA quantitative determination method | |
CN104991077B (en) | Troponin I competes turbidimetry detection kit | |
CN101788560A (en) | Enzyme-linked immunoassay kit for detecting residual chloramphenicol and detection method thereof | |
CN104076154A (en) | Enzyme linked immunosorbent assay kit detecting folic acid and application thereof | |
CN1888903B (en) | Enzyme-linked immune assay kit for detecting olaquindox | |
CN101299045B (en) | Method for detecting florfenicol and florfenicol amine and special-purpose enzyme-linked immunologic reagent kit thereof | |
CN102608316B (en) | Kit or test strip for detecting quinoxaline compound | |
CN101403752A (en) | Chemical luminescence ELISA detection kit for gatifloxacin | |
CN110256298B (en) | 4, 4' -dinitrophenylurea hapten and artificial antigen as well as preparation methods and application thereof | |
CN102827054B (en) | Hapten, artificial antigen and monoclonal antibody of L-hydroxyproline and preparation method and application thereof | |
CN104387431A (en) | Preparation method of high-specificity ribavirin artificial antigens | |
CN102539790A (en) | Enzyme-linked immunoassay kit for biotin | |
CN109810191A (en) | A kind of anti-ovine skeletal muscle Troponin I monoclonal antibody and its application | |
CN109705216A (en) | A kind of anti-bovine muscle Troponin I monoclonal antibody and its application | |
CN105399639A (en) | Tyramine artificial antigen and antibody, and preparation methods and application thereof | |
CN109956848A (en) | A kind of triclosan haptens and antigen and its preparation method and application | |
CN101241133A (en) | ELISA kit for detecting salbutamolum residue and method of use thereof | |
CN102539762B (en) | Enzyme-linked immunosorbent assay kit for detecting Sudan red and paranitroaniline red medicaments and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141112 Termination date: 20170825 |